GHULAM HOSSEIN KASHEF MD NPI 1679662688

NPI Information

  • NPI: 1679662688
  • Provider Name: GHULAM HOSSEIN KASHEF, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 10001 S EASTERN AVE STE 108
    HENDERSON, NV
    ZIP 89052
  • Phone: (702) 952-3444

Map and Directions

Get Directions

NPI Details

Ghulam Hossein Kashef, MD is a medical oncology internal medicine in Henderson, NV with 29 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Ghulam Hossein Kashef, MD NPI is 1679662688. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

10001 S EASTERN AVE STE 108
HENDERSON, NV
ZIP 89052
Phone: (702) 952-3444
Fax: (702) 952-3494

The NPI 1679662688 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
  • Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, iron dextran, 50 mg (HCPCS:J1750)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Nephelometry, test method using light (HCPCS:83883)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Protein measurement, serum (HCPCS:84165)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Urinalysis, manual test (HCPCS:81002)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Folic acid level, serum (HCPCS:82746)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)

The enumeration date for this NPI number is 10/11/2006 and was last updated on 2/29/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyME5786TEXASNo
2207RX0202XInternal MedicineMedical Oncology12706NEVADAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1W0150161OTHERTEXASDPS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.